Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1456]

ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer

ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer

Prenatal testing offers a window for finding a mother’s cancer risk

Prenatal testing offers a window for finding a mother’s cancer risk

ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower risk

ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower...

ASCO 2024: Risk reduction from HPV vaccination goes beyond cervical cancer

ASCO 2024: Risk reduction from HPV vaccination goes beyond cervical cancer

Scientists developing at-home swab tests for endometrial, ovarian cancer

Scientists developing at-home swab tests for endometrial, ovarian cancer

The role of three-dimensional power doppler for detecting ovarian cancer in adnexal masses

The role of three-dimensional power doppler for detecting ovarian cancer in adnexal masses

Rwanda initiative: public health boost with cervical cancer screening for 20,000

Rwanda initiative: public health boost with cervical cancer screening for 20,000

Study sheds light on cancer cell ‘tug-of-war’

Study sheds light on cancer cell ‘tug-of-war’

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV...

More from ecancer